Emel Aygören-Pürsün Person-Info 

( Ich bin Emel Aygören-Pürsün)

News

(1 - 4 von 14
)

Data of Deucrictibant for the On-Demand Treatment of HAE ...Moomoo App

www.moomoo.com
Presenter: Emel Aygören-Pürsün, M.D., University Hospital Frankfurt; Title: Efficacy and Safety of Oral Administered Bradykinin B2 Receptor Inhibitor ...

History of Changes for Study: NCT ClinicalTrials.gov

clinicaltrials.gov
Contact:Principal Investigator: Emel Aygören-Pürsün. Medizinische Hochschule Hannover [Recruiting] Hannover, Germany,

BioCryst Announces Positive Results from its APeX ...US Hereditary Angioedema Association

www.haea.org
— Emel Aygören-Pürsün, MD, principal investigator for the APeX-1 trial and Head of Interdisciplinary Competence Center for Hereditary Angioedema, ...

Orladeyo zeroes swelling attacks in HAE patientsAngioedema News

angioedemanews.com
— ... with no new safety signals observed, and attack reduction was sustained through 96 weeks [about two years],” Emel Aygören-Pürsün, MD, ...
Dossier exportieren
+1